June Reg Top Ten: From Excitement To Despair, A Month We Will Remember
This article was originally published in Clinica
June was an extraordinary month for news that will impact the EU medtech sector – and have global repercussions, for probably at least two decades. The second half of the month saw momentous decisions which will shape the future for all of us operating in the EU.
You may also be interested in...
February sees some vitally important issues on the European Commission’s agenda, including areas where the medtech sector has been clamoring for progress in terms of clarity over the Commission's thinking and guidance documents. This year's meetings are plentiful and critical.
While the EU has selected the CND system as the basis for its nomenclature, GMDN is becoming increasingly valued on the US and international scene. How does it see its latest role panning out globally?
Updated medtech notified body figures from the European Commission always make headline news. But industry needs to see real appointments now, not a list of tricky-to-understand numbers.